Sperm blocking study brings 'male pill' closer
Conclusion
This laboratory study has investigated the effects on male fertility of a blocked ejaculation process following the depletion of two genes in a group of genetically modified mice.
As the researchers say, there is a need for different approaches to male contraception because most strategies have so far focused on hormonal approaches that produce dysfunctional sperm. The researchers say these often have intolerable side effects, such as affecting male sexual activity or causing long-term irreversible effects on infertility.
This laboratory study demonstrated that 100% male infertility was achieved among a group ...
Source: NHS News Feed - December 3, 2013 Category: Consumer Health News Tags: Medical practice Medication Lifestyle/exercise Source Type: news
Male contraceptive pill 'a step closer'
Researchers announce discovery of proteins that can be blocked to prevent the launch of sperm cells during ejaculationA pill that provides a safe, effective and reversible method of contraception for men has been brought a step closer by scientists.Researchers identified two proteins that can be blocked to prevent the launch of sperm cells from the testes during ejaculation. Knocking out the proteins in genetically engineered mice resulted in male animals that were completely infertile, though they continued to mate normally. A similar goal could theoretically be achieved by suppressing the proteins with drugs, scientists ...
Source: Guardian Unlimited Science - December 2, 2013 Category: Science Tags: The Guardian Sex World news Health Society Contraception and family planning Science Source Type: news
Risk of Severe Hypotension in Men Treated With TamsulosinRisk of Severe Hypotension in Men Treated With Tamsulosin
Especially after starting or restarting treatment for benign prostatic hyperplasia, tamsulosin appears to be associated with an increased risk of severe hypotension. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2013 Category: Consumer Health News Tags: Urology News Source Type: news
Watchful waiting can do the job of BPH medications for some men
Many men over 50 take a daily medication to control bothersome urinary symptoms of benign prostatic hyperplasia (BPH). Yet there's an alternative called watchful waiting for men with mild to moderate BPH symptoms, reports the November 2013 Harvard Men's Health Watch. It basically means making lifestyle changes and monitoring symptoms closely until medication or other action is really necessary.
BPH, caused by an overgrown prostate gland, triggers a variety of problems, including frequent urination at night, difficulty completely emptying the bladder, and the urgent need to urinate at inconvenient times. "Watchful waiting i...
Source: New Harvard Health Information - November 3, 2013 Category: Consumer Health News Source Type: news
Sophiris starts dosing patients in Phase III study of prostate drug
Canadian urology firm Sophiris Bio has dosed the first patient in a Phase III trial of PRX302 (topsalysin) for the treatment for lower urinary tract symptoms of benign prostatic hyperplasia (BPH or enlarged prostate). (Source: Drug Development Technology)
Source: Drug Development Technology - October 29, 2013 Category: Pharmaceuticals Source Type: news
What Is BPH, or an Enlarged Prostate?
Benign prostatic hyperplasia (BPH), or "enlarged prostate," is a condition that can cause many of the (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - October 12, 2013 Category: Cancer & Oncology Authors: prostatecancer.guide at about.com Tags: health Source Type: news
FDA Approves Implant to Treat Urinary Symptoms Due to Benign Prostatic Hyperplasia (FREE)
By Kristin J. Kelley
The FDA has approved a new device to treat urinary symptoms in men ages 50 and older with benign prostatic hyperplasia. The UroLift system is … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 16, 2013 Category: Primary Care Source Type: news
Sophiris Bio Closes $65 Million Public Offering
SAN DIEGO and VANCOUVER, Aug. 23, 2013 -- (Healthcare Sales & Marketing Network) - Sophiris Bio Inc. (NASDAQ: SPHS, TSX: SHS) (the "Company" or "Sophiris"), a biopharmaceutical company developing a clinical-stage, targeted treatment fo... Biopharmaceuticals, Urology, Venture CapitalSophiris Bio, benign prostatic hyperplasia, PRX302 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2013 Category: Pharmaceuticals Source Type: news
Tadalafil Confirmed as Helpful in LUTS/BPHTadalafil Confirmed as Helpful in LUTS/BPH
Tadalafil improves lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), pooled data indicate. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 20, 2013 Category: Consumer Health News Tags: Urology News Source Type: news
Histologic prostatitis linked to sexual dysfunction in BPH
Researchers from China say that urologists must be more alert to the presence of histologic prostatitis in patients with benign prostatic hyperplasia, after finding that it is significantly associated with the risk for sexual dysfunction. (Source: MedWire News - Urology)
Source: MedWire News - Urology - August 19, 2013 Category: Urology & Nephrology Source Type: news
Enlarged Prostate - Many Options to Treat this Common Problem
The July issue of Mayo Clinic Health Letter covers how the prostate gland changes with age and ways to find relief for what's technically termed benign prostatic hyperplasia. (Source: Mayo Clinic Health Information)
Source: Mayo Clinic Health Information - July 24, 2013 Category: Consumer Health News Authors: Mayo Clinic Source Type: news
Enlarged Prostate - Many Options to Treat this Common Problem
The July issue of Mayo Clinic Health Letter covers how the prostate gland changes with age and ways to find relief for what's technically termed benign prostatic hyperplasia. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 24, 2013 Category: Databases & Libraries Authors: Mayo Clinic Source Type: news
Should You Use Avodart to Reduce Risk of...
Should you use Avodart to reduce your risk of prostate cancer? Avodart (otherwise known as dutasteride) has been used extensively in the past to treat men with benign prostatic hyperplasia (BPH). Learn more about it here. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 23, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Prostatic Urethral Lift for BPHProstatic Urethral Lift for BPH
Prostatic urethral lift, a minimally invasive procedure, relieves lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to a new study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2013 Category: Consumer Health News Tags: Urology News Source Type: news
What Is BPH or an Enlarged Prostate?
Benign prostatic hyperplasia (BPH) or "enlarged prostate" is a condition that can cause many of the same (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 5, 2013 Category: Cancer & Oncology Authors: prostatecancer.guide at about.com Tags: health Source Type: news
